Your browser doesn't support javascript.
loading
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes.
Neves, João Sérgio; Borges-Canha, Marta; Vasques-Nóvoa, Francisco; Green, Jennifer B; Leiter, Lawrence A; Granger, Christopher B; Carvalho, Davide; Leite-Moreira, Adelino; Hernandez, Adrian F; Del Prato, Stefano; McMurray, John J V; Ferreira, João Pedro.
Afiliação
  • Neves JS; Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal. Electronic address: jsneves@med.up.pt.
  • Borges-Canha M; Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal.
  • Vasques-Nóvoa F; Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal.
  • Green JB; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Leiter LA; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Granger CB; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Carvalho D; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal; Faculty of Medicine of the University of Porto, Porto, Portugal; Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
  • Leite-Moreira A; Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Cardiothoracic Surgery, Centro Hospitalar Universitário São João, Porto, Portugal.
  • Hernandez AF; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • McMurray JJV; British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
  • Ferreira JP; Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Université de Lorraine, Inserm, Centre d'Investigations Cliniques Plurithématique 14-33, and Inserm U1116, CHRU Nancy, Nancy, F-CRIN INI-CRCT (Cardiovascula
J Am Coll Cardiol ; 82(6): 517-525, 2023 08 08.
Article em En | MEDLINE | ID: mdl-37532422
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_cardiovascular_diseases / 6_diabetes / 6_endocrine_disorders Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_cardiovascular_diseases / 6_diabetes / 6_endocrine_disorders Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2023 Tipo de documento: Article